NYXOAH S A

Historical 13F Holders

Symbol
NYXH
CUSIP
B6S7WD106
All holders as of
Q2 2026
Type
Equity
Class
SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for B6S7WD106 since 12/18/2024, newest first.

Filer % of Class Filed
CVI Investments, Inc. 13G/A Amendment 1
9.9% 8/14/2026
Event 6/30/2026
ResMed Inc. 13G/A Amendment 2 2.0% 7/1/2026
Event 6/30/2026
Orin Hirschman 13G
14.5% 6/22/2026
Event 6/10/2026
Cochlear Ltd 13D/A Amendment 5
5.9% 6/11/2026
Event 6/10/2026
CVI Investments, Inc. 13G
9.9% 12/29/2025
Event 12/18/2025
Cochlear Ltd 13D/A Amendment 4
13.6% 11/24/2025
Event 11/20/2025
Vestal Point Capital, LP 13G/A Amendment 2
3.7% 8/14/2025
Event 6/30/2025
Vestal Point Capital, LP 13G/A Amendment 1
6.2% 5/15/2025
Event 3/31/2025
Vestal Point Capital, LP 13G
7.8% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 2.33 k $3.21 k
2026 Q2 45 22.1 M $37.5 M
2026 Q1 34 3.60 M $10.4 M
2025 Q4 33 3.71 M $16.8 M
2025 Q3 32 2.93 M $13.5 M
2025 Q2 32 3.90 M $29.2 M
2025 Q1 27 5.98 M $41.8 M
2024 Q4 23 6.78 M $54.4 M
2024 Q3 22 4.11 M $39.1 M
2024 Q2 25 4.35 M $30.4 M
2024 Q1 21 2.18 M $29.3 M
2023 Q4 19 2.34 M $10.9 M
2023 Q3 18 2.58 M $18.2 M
2023 Q2 17 2.64 M $21.1 M
2023 Q1 19 2.37 M $17.6 M
2022 Q4 19 2.65 M $13.3 M
2022 Q3 22 3.06 M $19.3 M
2022 Q2 24 3.20 M $29.8 M
2022 Q1 20 3.27 M $62.7 M
2021 Q4 16 2.68 M $60.9 M
2021 Q3 18 2.58 M $75.1 M
2021 Q2 1 191 k $5.75 M
2021 Q1 1 304 k $7.18 M
2020 Q4 1 296 k $5.73 M
2020 Q3 1 106 k $2.44 M